SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SE_02_033700605 | chr5:55850879-55867222![]() |
Sample_02_0337 | Haematopoietic and lymphoid tissue | MV411_untreat | 605 | 3 | 410 | 25 | 1 | 27 | 285 | IL31RA |
SE_02_025600632 | chr5:55850974-55870108![]() |
Sample_02_0256 | Peripheral blood | MV411 | 632 | 4 | 475 | 26 | 1 | 31 | 330 | IL31RA |
SE_02_062200289 | chr5:55851293-55870715![]() |
Sample_02_0622 | Blood | EOL1_Naive | 289 | 7 | 481 | 26 | 1 | 28 | 327 | IL31RA |
SE_02_046300328 | chr5:55852485-55865808![]() |
Sample_02_0463 | Blood | OCI-AML3 cells | 328 | 8 | 326 | 23 | 1 | 23 | 99 | IL31RA |
SE_02_046100454 | chr5:55854861-55869796![]() |
Sample_02_0461 | Blood | MV-4-11-B cells | 454 | 8 | 380 | 20 | 1 | 19 | 182 | IL31RA |
SE_02_104602738 | chr5:55887593-55933750![]() |
Sample_02_1046 | Peripheral blood | CD4+ cells_CTCL1145 | 2738 | 17 | 1204 | 65 | 1 | 72 | 995 | IL31RA,IL6ST |
SE_02_044401080 | chr5:55896233-55936091![]() |
Sample_02_0444 | Bone | osteosarcoma tumor P10 | 1080 | 14 | 1072 | 60 | 1 | 63 | 1015 | IL31RA,IL6ST |
SE_02_104300071 | chr5:55906012-56199913![]() |
Sample_02_1043 | Peripheral blood | Peripheral blood cells_CTCL1200 | 71 | 146 | 8174 | 415 | 26 | 490 | 2925 | IL31RA,IL6ST,ANKRD55,FLJ31104 |
SE_02_047600550 | chr5:55912456-55935694![]() |
Sample_02_0476 | iPSCs | hiPSC derived hepatocyte-like cells | 550 | 8 | 656 | 39 | 1 | 22 | 453 | IL31RA,IL6ST |
SE_02_032200620 | chr5:55913078-55936742![]() |
Sample_02_0322 | Colon | Caco-2 | 620 | 3 | 677 | 38 | 1 | 23 | 527 | IL6ST,IL31RA |
SE_02_104900070 | chr5:55922017-56172080![]() |
Sample_02_1049 | Peripheral blood | CD4+ cell_ROMI | 70 | 157 | 6995 | 354 | 25 | 426 | 2201 | IL31RA,IL6ST,FLJ31104,ANKRD55 |